Erectile dysfunction and testosterone levels prior to COVID-19 disease: What is the relationship?
https://doi.org/10.4081/aiua.2021.4.460
Accepted: October 9, 2021
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Objective: We aimed to investigate the relationship between COVID-19 and Erectile Dysfunction (ED) and the effect of serum testosterone level on the disease prognosis.
Methods: Between April-December 2020, 70 patients who were admitted with a complaint of ED after having COVID-19 and whose serum testosterone level was checked for varicocele, premature ejaculation, and infertility reasons before COVID-19. The patients filled the International Index of Erectile Function (IIEF-5) and their testosterone level was checked. The questionnaire was arranged to assess the first month before COVID-19 and after COVID-19. Testosterone levels of the patients before and after COVID-19 were compared. The relationship between testosterone levels and hospitalization in the intensive care was evaluated.
Results: It was revealed that testosterone levels and IIEF-5 scores after COVID-19 in all patients were statisticaly and significantly different compared to the period before COVID-19 (p < 0.05). Testosterone levels of patients in need of intensive care were significantly higher than those without any need of intensive care (p < 0.05).
Conclusions: Our study has presented that COVID-19 may cause ED and high testosterone levels increase the rate of hospitalization in the intensive care by intensifying the disease.
Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med 2020;8:e46-e47. DOI: https://doi.org/10.1016/S2213-2600(20)30216-2
Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198-209. DOI: https://doi.org/10.1111/his.14134
Jannini EA. SM = SM: The interface of systems medicine and sexual medicine for facing non-communicable diseases in a genderdependent manner. Sex Med Rev. 2017; 5:349-364. DOI: https://doi.org/10.1016/j.sxmr.2017.04.002
Isidori AM, Buvat J, Corona G, et al. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014; 65:99-112. DOI: https://doi.org/10.1016/j.eururo.2013.08.048
Schubert M, Jockenhovel F. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects. J Endocrinol Invest. 2005; 28:23-27.
Blute M, Hakimian P, Kashanian J, et al. Erectile dysfunction and testosterone deficiency. Front Horm Res. 2009;37:108-122. DOI: https://doi.org/10.1159/000176048
Mohamed MS, Moulin TC, Schiöth HB. Sex differences in COVID-19: the role of androgens in disease severity and progression.Endocrine. 2021; 71:3-8. DOI: https://doi.org/10.1007/s12020-020-02536-6
Rodriguez Bustos H, Bravo Maturana G, Cortés-Chau F, et al. Effects of COVID-19 on male sex function and its potential sexual transmission. Arch Ital Urol Androl. 2021; 93:48-52. DOI: https://doi.org/10.4081/aiua.2021.1.48
Papadopoulos V, Li L, Samplaski M. Why does COVID-19 kill more elderly men than women? Is there a role for testosterone? Andrology. 2021; 9:65-72. DOI: https://doi.org/10.1111/andr.12868
Maretti C, Privitera S, Arcaniolo D, et al. COVID-19 pandemic and its implications on sexual life: Recommendations from the Italian Society of Andrology. Arch Ital Urol Androl. 2020; 92:73-77 DOI: https://doi.org/10.4081/aiua.2020.2.73
Delle Fave RF, Polisini G, Giglioni G, et al. COVID-19 and male fertility: Taking stock of one year after the outbreak began. Arch Ital Urol Androl. 2021; 93:115-119. DOI: https://doi.org/10.4081/aiua.2021.1.115
Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Primers. 2016; 2:16003. DOI: https://doi.org/10.1038/nrdp.2016.3
Irwin GM. Erectile dysfunction. Prim Care. 2019; 46:249-255. DOI: https://doi.org/10.1016/j.pop.2019.02.006
Guay AT. ED2: erectile dysfunction = endothelial dysfunction. Endocrinol Metab Clin North Am. 2007; 36:453-463. DOI: https://doi.org/10.1016/j.ecl.2007.03.007
Mola JR. Erectile dysfunction in the older adult male. Urol Nurs. 2015; 35:87-93 DOI: https://doi.org/10.7257/1053-816X.2015.35.2.87
Nguyen HMT, Gabrielson AT, Hellstrom WJG. Erectile dysfunction in young men-A review of the prevalence and risk factors. Sex Med Rev. 2017; 5:508-520. DOI: https://doi.org/10.1016/j.sxmr.2017.05.004
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395:1417-1418. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5
Maiorino MI, Bellastella G, Giugliano D, et al. From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest. 2018; 41:1249-1258. DOI: https://doi.org/10.1007/s40618-018-0872-6
Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020; 46:586-590. DOI: https://doi.org/10.1007/s00134-020-05985-9
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-273. DOI: https://doi.org/10.1038/s41586-020-2012-7
Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203:631-637. DOI: https://doi.org/10.1002/path.1570
Lovren F, Pan Y, Quan A, et al. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am. J. Physiol. Circ. Physiol. 2008; 295: H1377-H1384. DOI: https://doi.org/10.1152/ajpheart.00331.2008
Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241-7. DOI: https://doi.org/10.1210/jc.2007-1245
Aksam A Yassin, Farid Saad. Testosterone and erectile dysfunction. J Androl. 2008; 29:593-604. DOI: https://doi.org/10.2164/jandrol.107.004630
Rizk PJ, Kohn TP, Pastuszak AW, Khera M. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr Opin Urol. 2017; 27:511-515. DOI: https://doi.org/10.1097/MOU.0000000000000442
Douglas GC, O’Bryan MK, Hedger MP, et al. The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology. 2004; 145:4703-4711. DOI: https://doi.org/10.1210/en.2004-0443
Ma L, Xie W, Li D, et al. Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study. MedRxiv; 2020. DOI: https://doi.org/10.1101/2020.03.21.20037267
Vanhorebeek I, Langouche L, Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab. 2006; 2:20-31. DOI: https://doi.org/10.1038/ncpendmet0071
Okçelik S. COVID-19 pneumonia causes lower testosterone levels. Andrologia. 2021; 53:e13909. DOI: https://doi.org/10.1111/and.13909
Mohamad NV, Wong SK, Wan Hasan WN. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019; 22:129-140. DOI: https://doi.org/10.1080/13685538.2018.1482487
Malkin CJ, Pugh PJ, Jones RD, et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men J Clin Endocrinol Metab. 2004; 89:3313-8. DOI: https://doi.org/10.1210/jc.2003-031069
Chen J, Jiang Q, Xia X, et al. Individual variation of the SARSCoV-2 receptor ACE2 gene expression and regulation. Aging Cell.2020; 19:e13168. DOI: https://doi.org/10.1111/acel.13168
Giagulli VA, Guastamacchia E, Magrone T, et al. Worse progression of COVID-19 in men: Is testosterone a key factor? Andrology. 2021; 9:53-64. DOI: https://doi.org/10.1111/andr.12836
Çayan S, Ug˘uz M, Saylam B, Akbay E. Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARSCoV-2 infected male patients: a cohort study. Aging Male. 2020; 23:1493-1503. DOI: https://doi.org/10.1080/13685538.2020.1807930
Rastrelli G, Di Stasi V, Inglese F, et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology. 2021; 9:88-98. DOI: https://doi.org/10.1111/andr.12821
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426:450-454. DOI: https://doi.org/10.1038/nature02145
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181:271-280.e8. DOI: https://doi.org/10.1016/j.cell.2020.02.052
Heurich A, Hofmann-Winkler H, Gierer S, et al. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014; 88:1293-1307. DOI: https://doi.org/10.1128/JVI.02202-13
Wambier CG, Goren A. Severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020; 83:308-309. DOI: https://doi.org/10.1016/j.jaad.2020.04.032
Rozhivanov RV, Andreeva EN, Melnichenko GA, Mokrysheva NG. Androgens and Antiandrogens influence on COVID-19 disease in men. Probl Endokrinol (Mosk). 2020; 66:77-81. DOI: https://doi.org/10.14341/probl12500
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
